Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,284,538
  • Shares Outstanding, K 95,637
  • Annual Sales, $ 9,560 K
  • Annual Income, $ -212,220 K
  • 60-Month Beta 0.90
  • Price/Sales 443.27
  • Price/Cash Flow N/A
  • Price/Book 5.10
Trade RNA with:

Options Overview Details

View History
  • Implied Volatility 72.98% ( -0.12%)
  • Historical Volatility 92.46%
  • IV Percentile 19%
  • IV Rank 28.39%
  • IV High 161.97% on 11/16/23
  • IV Low 37.71% on 08/18/23
  • Put/Call Vol Ratio 0.22
  • Today's Volume 73
  • Volume Avg (30-Day) 441
  • Put/Call OI Ratio 1.76
  • Today's Open Interest 6,909
  • Open Int (30-Day) 7,370

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.76
  • Number of Estimates 4
  • High Estimate -0.60
  • Low Estimate -0.93
  • Prior Year -0.66
  • Growth Rate Est. (year over year) -15.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.63 +22.30%
on 07/05/24
45.19 -0.86%
on 07/12/24
+6.44 (+16.79%)
since 06/12/24
3-Month
22.24 +101.44%
on 04/19/24
45.19 -0.86%
on 07/12/24
+20.71 (+85.97%)
since 04/12/24
52-Week
4.82 +828.50%
on 10/31/23
45.19 -0.86%
on 07/12/24
+33.58 (+299.29%)
since 07/12/23

Most Recent Stories

More News
Avidity Biosciences (RNA) Stock Surges on Positive AOC 1020 Trial Results

Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase comes following impressive results from Avidity’s AOC 1020 clinical trial...

RNA : 44.80 (+1.11%)
Chart of the Day: Avidity Biosciences --- Something's Up???

Author's Note: Every once in a while I see a stock where most analysts predict decreasing Revenue and Earnings but they all seem to recommend it anyway — Here is a good example. Please tell my what...

RNA : 44.80 (+1.11%)
Oracle, Casey's General Stores rise; Vera Bradley, PetMed fall, Wednesday, 6/12/2024

Stocks that traded heavily or had substantial price changes on Wednesday: Oracle, Casey’s General Stores rise; Vera Bradley, PetMed fall

FCX : 51.28 (-0.45%)
RNA : 44.80 (+1.11%)
PETS : 3.92 (+0.77%)
PARAA : 21.40 (-0.14%)
VRA : 6.49 (unch)
CASY : 376.44 (+0.11%)
ORCL : 144.77 (+1.41%)
2 Potentially High-Reward Growth Stocks to Buy Right Now

These two biotechnology stocks could be gearing up for a run.

RNA : 44.80 (+1.11%)
LRMR : 10.49 (+7.04%)
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 44.23 (+4.61%)
VKTX : 57.18 (-2.47%)
LBPH : 36.83 (-3.99%)
ARQT : 10.62 (-1.03%)
RNA : 44.80 (+1.11%)
Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

New AOC 1001 data demonstrate improvement in additional functional measures including hand grip, muscle strength and patient reported outcomes, augmenting...

RNA : 44.80 (+1.11%)
Avidity Biosciences to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

RNA : 44.80 (+1.11%)
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

RNA : 44.80 (+1.11%)
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 13, 2023 – USA News Group  –  Sufferers of many different ailments saw reason to grow their hope in 2022 when...

ONCY : 1.0400 (+1.96%)
ONC.TO : 1.44 (+2.86%)
FULC : 8.01 (+2.69%)
RNA : 44.80 (+1.11%)
BCTX : 0.8842 (-3.15%)
BCT.TO : 1.20 (-4.00%)
GILD : 69.96 (-0.01%)
Avidity Biosciences Joins with Patient Communities to Raise Awareness During National Muscular Dystrophy Awareness Month as it Advances Three Muscular Dystrophy Clinical Programs

Avidity supports World Duchenne Awareness Day, International Myotonic Dystrophy Awareness Day, FSHD Society Walk & Roll to Cure FSHD and Global Genes Week in...

RNA : 44.80 (+1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the...

See More

Key Turning Points

3rd Resistance Point 46.77
2nd Resistance Point 45.98
1st Resistance Point 45.39
Last Price 44.80
1st Support Level 44.01
2nd Support Level 43.22
3rd Support Level 42.63

See More

52-Week High 45.19
Last Price 44.80
Fibonacci 61.8% 29.77
Fibonacci 50% 25.01
Fibonacci 38.2% 20.24
52-Week Low 4.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar